Federal officials say they will keep closer tabs on private companies that run Medicare plans and Medicare prescription drug plans.
The Centers for Medicare and Medicaid Service announced today that it is proposing new compliance requirements for vendors in the Medicare Advantage and Medicare Part D prescription drug plan programs.
The CMS now will take "new steps to help expose potential fraud or misconduct through mandatory self-reporting," officials say.
The CMS also will streamline the process for imposing intermediate sanctions and clarify the process for imposing civil money penalties, officials say.